Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure
- 27 October 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (9) , 1825-1830
- https://doi.org/10.1016/j.jacc.2004.05.087
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Therapeutic strategies in heart failure: what is the optimal sequence of drug therapy?European Heart Journal Supplements, 2003
- Pharmacotherapy of chronic heart failure: current status and future aspectsEuropean Heart Journal Supplements, 2002
- Carvedilol Decreases Elevated Oxidative Stress in Human Failing MyocardiumCirculation, 2002
- Overview of Recent Clinical Trials in Heart Failure: What Is the Current Standard of Care?Cardiology in Review, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart DiseasePublished by Elsevier ,1998
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978